4
Changes in Ownership
Lipocine Inc. Filed Acc 0001638599-19-001011
EVP and Chief Financial Office sold 17,250 shares at $0.41 ($7,076)
- EVP and Chief Financial Office acquired 57,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/doc4_6380.xml…